Chemoinformaics analysis of 2-Cyclohexen-1-one, 3,5,5-trimethyl-4-methylene-
Molecular Weight | 150.221 | nRot | 0 |
Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
Exact Molecular Weight | 150.104 | nRing | 1 |
Solubility: LogS | -2.408 | nHRing | 0 |
Solubility: LogP | 2.462 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.518 |
Synth | 3.328 |
Natural Product Likeliness | 2.202 |
NR-PPAR-gamma | 0.14 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.495 |
MDCK | 0.0000301 |
BBB | 0.068 |
PPB | 0.754822 |
VDSS | 1.669 |
FU | 0.378702 |
CYP1A2-inh | 0.724 |
CYP1A2-sub | 0.839 |
CYP2c19-inh | 0.764 |
CYP2c19-sub | 0.861 |
CYP2c9-inh | 0.234 |
CYP2c9-sub | 0.791 |
CYP2d6-inh | 0.055 |
CYP2d6-sub | 0.63 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.309 |
CL | 7.966 |
T12 | 0.677 |
hERG | 0.014 |
Ames | 0.046 |
ROA | 0.666 |
SkinSen | 0.9 |
Carcinogencity | 0.9 |
EI | 0.751 |
Respiratory | 0.907 |
NR-Aromatase | 0.055 |
Antiviral | No |
Prediction | 0.918482 |